Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 2/3 1Phase 1 1

Status

Completed 3Unknown 2

Sponsor Class

OTHER 3

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

NET 1Head & Neck 1Endocrine 1Breast 1

Conditions

Primary Breast Cancer 1Neuroendocrine Tumors 1Malignancy of Thyroid Nodules 1

Interventions

Cyclophosphamide 1492Cisplatin 1414Paclitaxel 1317Radiotherapy 1261Carboplatin 1250Gemcitabine 1215Docetaxel 1109Bevacizumab 1030Fluorouracil 894Doxorubicin 792Dexamethasone 748Rituximab 719Capecitabine 716Oxaliplatin 700pembrolizumab 680Etoposide 678Irinotecan 634Filgrastim 621Cytarabine 586Leucovorin 579Nivolumab 558Vincristine 515Prednisone 475Cetuximab 465Bortezomib 459Erlotinib Hydrochloride 456Trastuzumab 447Methotrexate 438Lenalidomide 427Pemetrexed 420

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Interventional × Iodine-123 × Clear all
NCT03498183 2025-06-06

MIBI-THYR

Nantes University Hospital

Phase 2/3 Completed
372 enrolled
Head & Neck

Malignancy of Thyroid Nodules

NCT05923177 2025-04-09

Molecular Imaging of HER2 Expression in Breast Cancer Using [123I] I-(HE)3-G3

Tomsk National Research Medical Center of the Russian Academy of Sciences

Phase 1 Completed
10 enrolled
Breast

Primary Breast Cancer

NCT04510311 2025-01-10

Imaging Properties of PET Radiotracer [18F]3F-PHPG in Patients With Neuroendocrine Tumors

University of Michigan Rogel Cancer Center

Phase EARLY_PHASE1 Completed
32 enrolled
EndocrineNET

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡